Robert L. Rodnitzky

 

 Buy Article Permissions and Reprints

The Guest Editor of this issue of Seminars in Neurology on Movement Disorders is Dr. Robert Rodnitzky. Dr. Rodnitzky is a legendary figure in neurology. He obtained his Bachelor of Science degree from the University of Chicago and his M.D. from the University of Chicago School of Medicine. He trained in Neurology at the University of Iowa and has been there ever since, leaving only to serve as Lieutenant Commander in the U.S. Navy and for a sabbatical leave to study Movement and Motor Physiology at Stanford University. He is presently Professor and Interim Chairman of Neurology at the University of Iowa. He has mentored several Movement Disorder Fellows, has received many teaching awards, and has been listed in Best Doctors in America since 1995. He presently serves on the National Institutes of Health Data and Safety Monitoring Board for Neuroprotection Initiative in Parkinson's disease (NET-PD), and is part of the leadership of the University of Iowa Hospitals. He is an outstanding educator and has been invited to lecture at several academic centers both in the United States and throughout the world and is a regular part of the Faculty at the American Academy of Neurology. Dr. Rodnitzky is a prolific author who has contributed multiple chapters to neurological textbooks and multiple manuscripts to the literature. He writes about Parkinson's disease and the parkinsonian syndromes, drug-induced movement disorders, neuroprotective agents for parkinsonism and other related topics.

In this issue of Seminars of Neurology, Dr. Rodnitzky has assembled a faculty that reviews the current state of the pharmacotherapy of Parkinson's disease; neuroprotective therapies in Parkinson's disease; guidelines to help the clinician distinguish Parkinson's disease from other conditions; the pathophysiology, clinical features, and treatment of Wilson's disease; trinucleotide repeat disorders; Huntington's disease; dystonia; iatrogenic movement disorders; deep brain stimulation for Parkinson's disease; and botulinum toxin therapy for movement disorders. We are terribly grateful to Dr. Rodnitzky and to all the contributors of this issue of Seminars in Neurology for providing us with a comprehensive and exciting update on movement disorders.

Karen L RoosM.D. 

Indiana University School of Medicine

550 North University Blvd., Suite 4411, Indianapolis, IN 46202-5124